SCHEMBL9639477

SCHEMBL9639477

N#CC(C(=O)c1cccs1)C(N)=S

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.45
CES1 P23141 2/20 0.45
KEAP1 Q14145 1/20 0.45
DAO P14920 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
GAA P10253 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 3/20 0.40
LMNA P02545 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MEN1 O00255 2/20 0.40
POLB P06746 2/20 0.40
HDAC1 Q13547 1/20 0.40
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAPK10 P53779 1/20 0.39
HPGD P15428 2/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10445514 0.75 ALDH1A1 (0.45) CES2CES1KEAP1SMN1; SMN2GAA
SCHEMBL10445363 0.74 NPC1 (0.48) SMN1; SMN2GAAALDH1A1KMT2ALMNA
SCHEMBL12539406 0.73 ALDH1A1 (0.50) CES2CES1KEAP1DAOSMN1; SMN2
SCHEMBL6829927 0.72 GAA (0.43) SMN1; SMN2GAAALDH1A1KMT2ALMNA
SCHEMBL10445504 0.72 KMT2A (0.48) SMN1; SMN2KMT2ALMNANPC1RAB9A
SCHEMBL10445322 0.71 LMNA (0.58) SMN1; SMN2GAAALDH1A1KMT2ALMNA
SCHEMBL10445334 0.70 HSPA5 (0.56) SMN1; SMN2HSD17B10ALDH1A1KMT2ALMNA
SCHEMBL7163607 0.68 ALDH1A1 (0.51) CES2CES1KEAP1DAOSMN1; SMN2
SCHEMBL26056789 0.68 CES2 (0.66) CES2CES1KEAP1DAOSMN1; SMN2
SCHEMBL6829315 0.68 ALDH1A1 (0.41) CES2CES1SMN1; SMN2GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0326107-B1 ANTIARTHRITIC BETA-CYCLOALKYL-BETA-OXOPROPIONITRILES Bristol-Myers Squibb Company (US) 1992-09-02 EP disclosed
US-4975462-A Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives BRISTOL-MYERS COMPANY (US) 1990-12-04 US disclosed
EP-0352812-A1 Antiarthritic alpha-arylcarbamoyl cyanoacetic acid derivatives Bristol-Myers Squibb Company (US) 1990-01-31 EP disclosed
US-4888357-A ANTIINFLAMMATORY AGENTS BRISTOL-MYERS COMPANY (US) 1989-12-19 US disclosed
EP-0326107-A1 Antiarthritic beta-cycloalkyl-beta-oxopropionitriles Bristol-Myers Squibb Company (US) 1989-08-02 EP disclosed